SAGE Therapeutics Inc (SAGE) is around the middle of the Biotechnology industry according to InvestorsObserver. SAGE received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. SAGE Therapeutics Inc also achieved a score of 60 in the Biotechnology industry, putting it above 60 percent of Biotechnology stocks. Biotechnology is ranked 111 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

SAGE Therapeutics Inc (SAGE) stock is trading at $55.69 as of 11:47 AM on Thursday, Jun 17, an increase of $0.81, or 1.48% from the previous closing price of $54.88. The stock has traded between $53.80 and $56.36 so far today. Volume today is 872,840 compared to average volume of 911,752.

Click Here to get the full Stock Score Report on SAGE Therapeutics Inc (SAGE) Stock.

Read more:
Is SAGE Therapeutics Inc (SAGE) Stock at the Top of the Biotechnology Industry? - InvestorsObserver